# A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)

> **NCT00788710** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 430 (actual)

## Conditions studied

- Acute Pain Following a Total Abdominal Hysterectomy

## Interventions

- **DRUG:** etoricoxib (MK0663) 120 mg
- **DRUG:** Comparator: Placebo
- **DRUG:** etoricoxib (MK0663) 90 mg

## Key facts

- **NCT ID:** NCT00788710
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788710, "A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00788710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*